In a laboratory in China’s southern city of Guangzhou, scientists are trying to enhance the rare sweet wormwood shrub, from which artemisinin — the best drug to fight malaria — is derived.
China hopes to improve and use the drug as a uniquely Chinese weapon to fight malaria not on its own soil, where the deadly disease has been sharply pruned back, but in Africa, where it still kills one child every 30 seconds.
Already, a Beijing-backed eradication program on a small island off Africa has proven a huge success.
Away from its practical application, scientists back in the lab in Guangzhou are also achieving results. In one of the lab’s refrigerators sit a dozen triangular test-tubes holding seedlings of the sweet wormwood shrub, also called Artemisia annua, which has only been found in the wild in China, Vietnam and border areas in Myanmar.
“There are about 0.6 parts of artemisinin in every 100 parts of the plant in the wild, but we have managed to increase the artemisinin content to between 1.2 and 1.8,” said Feng Liling (馮麗玲), assistant professor at the Tropical Medicine Institute in Guangzhou University of Traditional Chinese Medicine.
China pledged to help Africa fight malaria at the triennial Forum on China and Africa Cooperation (FOCAC) in 2006 and has since set up 30 anti-malaria and prevention units. The next FOCAC meeting is in Egypt tomorrow and Monday.
Helping developing countries eradicate malaria will help China project its influence and prestige as a global power, politics professor Joseph Cheng (鄭宇碩) at the City University of Hong Kong said.
“China is exploring cost effective ways to help the Third World and is interested in making distinct contributions,” Cheng said, adding that Western interest was often lacking in a disease that seldom afflicts rich countries’ citizens.
“Malaria suits these requirements. It is not that expensive. It is cheaper than fighting AIDS,” Cheng said.
Tanzania, Kenya and Nigeria have begun farming hybrids of the sweet wormwood shrub with Chinese and Vietnamese ancestry, said Li Guoqiao (李國橋) at the Tropical Medicine Institute.
“I inspected the plantations and the plants are growing well,” Li said.
Asked if China would export the high-yielding Artemisia annua to Africa, Li said: “We want to grow them in China and whatever we export depends on bilateral relationships.”
Li is spearheading a project on the tiny African island of Moheli, which belongs to the Comoros group of islands at the northern mouth of the Mozambique Channel.
In mid-November 2007, he launched a “mass drug administration” exercise on the island. Its entire population of 36,000 had to take two courses of anti-malarial drugs to flush the parasite from their bodies.
The rationale was that while mosquitoes pass the parasite from person to person, they are merely “vectors” and not hosts. The real reservoir of the disease is people, and many carry the parasite in their bodies without even showing symptoms.
“The key is to eradicate the source, which is in people. Without the source, the vectors are harmless,” he said.
The results were startling. While the parasite carrier rate in Moheli ranged from 5 to 94 percent from village to village before the exercise, that fell to 1 percent or less from January last year and has stayed around that figure since.
An endangered baby pygmy hippopotamus that shot to social media stardom in Thailand has become a lucrative source of income for her home zoo, quadrupling its ticket sales, the institution said Thursday. Moo Deng, whose name in Thai means “bouncy pork,” has drawn tens of thousands of visitors to Khao Kheow Open Zoo this month. The two-month-old pygmy hippo went viral on TikTok and Instagram for her cheeky antics, inspiring merchandise, memes and even craft tutorials on how to make crocheted or cake-based Moo Dengs at home. A zoo spokesperson said that ticket sales from the start of September to Wednesday reached almost
A 64-year-old US woman took her own life inside a controversial suicide capsule at a Swiss woodland retreat, with Swiss police on Tuesday saying several people had been arrested. The space-age looking Sarco capsule, which fills with nitrogen and causes death by hypoxia, was used on Monday outside a village near the German border. The portable human-sized pod, self-operated by a button inside, has raised a host of legal and ethical questions in Switzerland. Active euthanasia is banned in the country, but assisted dying has been legal for decades. On the same day it was used, Swiss Department of Home
‘CLOSER TO THE END’: The Ukrainian leader said in an interview that only from a ‘strong position’ can Ukraine push Russian President Vladimir Putin ‘to stop the war’ Decisive actions by the US now could hasten the end of the Russian war against Ukraine next year, Ukrainian President Volodymyr Zelenskiy said on Monday after telling ABC News that his nation was “closer to the end of the war.” “Now, at the end of the year, we have a real opportunity to strengthen cooperation between Ukraine and the United States,” Zelenskiy said in a post on Telegram after meeting with a bipartisan delegation from the US Congress. “Decisive action now could hasten the just end of Russian aggression against Ukraine next year,” he wrote. Zelenskiy is in the US for the UN
TIGHTENING: Zhu Hengpeng, who worked for an influential think tank, has reportedly not been seen in public since making disparaging remarks on WeChat A leading Chinese economist at a government think tank has reportedly disappeared after being disciplined for criticizing Chinese President Xi Jinping (習近平) in a private chat group. Zhu Hengpeng (朱恆鵬), 55, is believed to have made disparaging remarks about China’s economy, and potentially about the Chinese leader specifically, in a private WeChat group. Zhu was subsequently detained in April and put under investigation, the Wall Street Journal reported. Zhu worked for the Chinese Academy of Social Sciences (CASS) for more than 20 years, most recently as the Institute of Economics deputy director and director of the Public Policy Research Center. He